Mackenzie Financial
IPXL

Mackenzie Financial’s Impax Laboratories, Inc. IPXL Stock Holding History

Mackenzie Financial’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,587
Closed -$593K – 916
2016
Q2 		$593K Buy
20,587
+200
+1% +$6.52K ﹤0.01% 730
2016
Q1 		$653K Buy
+20,387
New +$717K 0.01% 607

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mackenzie Financial's IPXL Position: Q3 2016 in Review

Mackenzie Financial sold out of Impax Laboratories, Inc. (IPXL) in Q3 2016, closing a stake of 20,587 shares — an estimated $593K sold.

Mackenzie Financial first reported a position in IPXL in Q1 2016 and held it in 2 quarters. The position peaked at $653K in Q1 2016. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

  • Mackenzie Financial reported no remaining Impax Laboratories, Inc. position as of Q3 2016 after selling out during the quarter.
  • Mackenzie Financial sold 20,587 Impax Laboratories, Inc. shares in Q3 2016, an estimated $593K.
  • Mackenzie Financial first reported a position in Impax Laboratories, Inc. in Q1 2016 and held it in 2 quarters.
  • Mackenzie Financial's Impax Laboratories, Inc. position peaked at $653K in Q1 2016.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Mackenzie Financial's 13F filing for Q3 2016, filed 15 Nov 2016.